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ABSTRACT A new form of metabolic ﬂux analysis (MFA) called thermodynamics-based metabolic ﬂux analysis (TMFA) is
introduced with the capability of generating thermodynamically feasible ﬂux and metabolite activity proﬁles on a genome scale.
TMFA involves the use of a set of linear thermodynamic constraints in addition to the mass balance constraints typically used in
MFA. TMFA produces ﬂux distributions that do not contain any thermodynamically infeasible reactions or pathways, and it
provides information about the free energy change of reactions and the range of metabolite activities in addition to reaction
ﬂuxes. TMFA is applied to study the thermodynamically feasible ranges for the ﬂuxes and the Gibbs free energy change, DrG9,
of the reactions and the activities of the metabolites in the genome-scale metabolic model of Escherichia coli developed by
Palsson and co-workers. In the TMFA of the genome scale model, the metabolite activities and reaction DrG9 are able to
achieve a wide range of values at optimal growth. The reaction dihydroorotase is identiﬁed as a possible thermodynamic
bottleneck in E. coli metabolism with a DrG9 constrained close to zero while numerous reactions are identiﬁed throughout
metabolism for which DrG9 is always highly negative regardless of metabolite concentrations. As it has been proposed
previously, these reactions with exclusively negative DrG9 might be candidates for cell regulation, and we ﬁnd that a signiﬁcant
number of these reactions appear to be the ﬁrst steps in the linear portion of numerous biosynthesis pathways. The thermo-
dynamically feasible ranges for the concentration ratios ATP/ADP, NAD(P)/NAD(P)H, and H1extracellular/H
1
intracellular are also deter-
mined and found to encompass the values observed experimentally in every case. Further, we ﬁnd that the NAD/NADH and
NADP/NADPH ratios maintained in the cell are close to the minimum feasible ratio and maximum feasible ratio, respectively.
INTRODUCTION
Thermodynamics have been applied to many areas of
analysis of biological systems (1–5), but thermodynamics
have yet to be applied to a rigorous examination of entire
metabolic networks. This has been primarily due to a scarcity
of thermodynamic data on metabolic reactions, a lack of
rigorous models of metabolic chemistry, and the absence of
any extensive databases, which bring all of this information
together. However, the availability of thermodynamic data
has increased over time, and group contribution methodol-
ogies for estimating thermodynamic properties have also
been introduced (6–9). Furthermore, several rigorous models
of the metabolic chemistry of a variety of microorganisms
have been developed including some genome-scale models
(10–13). Recently, the application of thermodynamics to
study the feasibility of metabolic pathways has been
revisited. Beard, Qian, and co-workers have conducted
studies on the topic of eliminating internal ﬂux cycles from
ﬂux balance analysis solutions (14–16). These are sets of
reactions such as A/B/C/A. According to the ﬁrst law
of thermodynamics, the overall thermodynamic driving force
through these cycles must be zero, meaning that no net ﬂux is
possible through these cycles. Beard and Qian have also used
nonlinear thermodynamic and enzyme activity constraints to
determine the concentration proﬁles of metabolites in the
central carbon chemistry of a hepatocyte cell (17). Maskow
and Stockar used the pathway analysis method of Mavro-
vouniotis (18,19) to study the thermodynamic feasibility of
the lactic acid fermentation pathway, and they found that
without careful consideration of ionic strength of solution,
uncertainty in thermodynamic data, and cell pH, feasible
pathways can be falsely labeled as infeasible or vice versa
(20). However, these previous studies were performed on
relatively small-scale pathways due to a lack of thermody-
namic data for genome-scale models and utilized nonlinear
optimization criteria to determine ﬁxed values for the activities
of the metabolites under an isolated set of conditions.
In a previous article, we utilized the group contribution
method (7,8) to estimate the standard Gibbs free energy
change, DrG9, of the reactions in a genome-scale model of
Escherichia coli, and we used these estimates to assess the
thermodynamic feasibility of the reactions in the model (21).
We called this model iHJ873, which is based on the iJR904
model developed by Palsson and co-workers. The iHJ873
model was derived from the iJR904 model by removing all
of the reactions in the iJR904 model that contain compounds
for which the standard Gibbs free energy change of
formation, DfG9, could not be estimated and replacing
these reactions with lumped reactions. The iHJ873 model
contains fewer reactions than the iJR904model (873 vs. 931,
respectively), but DrG9 of every reaction in the iHJ873 can
be estimated. The thermodynamic studies of the iHJ873
model focused on the individual reactions in the model that
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were found to have a large positive DrG9 in the direction of
ﬂux. We simulated the impact of removing these unfavorable
reactions on the growth of the cell, and we considered the
biological implications that these particular reactions were
thermodynamically unfavorable. In this article, we take this
work a signiﬁcant step forward by examining the metabolite
concentrations required for every reaction essential for
optimal growth to be simultaneously thermodynamically
feasible. We propose a new methodology that we call
thermodynamics-based metabolic ﬂux analysis (TMFA) for
integrating thermodynamic data and constraints into a
constraints-based metabolic model to ensure that ﬂux
distributions produced by the model are thermodynamically
feasible and to provide data on the thermodynamically
feasible metabolite activity ranges for the metabolites in the
cell. TMFA can also be used for the analysis of unmodiﬁed
models that are lacking some thermodynamic data to allow
for direct analysis of models such as iJR904 without ﬁrst
creating lumped models like the iHJ873. We apply TMFA to
analyze the iJR904 model using new thermodynamic data
estimated from an updated and expanded implementation of
the group contribution method (M. D. Jankowski, C. S.
Henry, L. J. Broadbelt and V. Hatzimanikatis, unpublished);
we assess the sensitivity of TMFA to changes in DrG9 due to
uncertainty and ionic strength; and we examine the thermo-
dynamically feasible ranges for biologically important con-
centrations ratios such as ATP/ADP, NAD(P)/NAD(P)H,
and H1extracellular/H
1
intracellular. Finally, we utilize the DrG9
ranges calculated for the iJR904 reactions with TMFA to
identify candidate reactions for cell regulation as it has been
previously proposed (2).
METHODS
Metabolic ﬂux analysis (MFA)
TMFA uses at its core the mass balance constraints of metabolic ﬂux
analysis (MFA) (13,23–25). MFA deﬁnes the limits on the metabolic
capabilities of a model organism under steady-state ﬂux conditions by
constraining the net production rate of every metabolite in the system to
zero as
N  v ¼ 0; (1)
where N is an m 3 r matrix of the stoichiometric coefﬁcients for the r
reactions and m metabolites in the model, and v is an r 3 1 vector of the
steady-state ﬂuxes through the r reactions in the model. MFA is combined
with optimization to determine the limits on the ability of the cell to produce
biochemicals such as ethanol (26,27), to predict the maximum possible
growth yields of the cell (28–30), and to predict the responses to gene
knockouts and additions (31,32).
The introduction of thermodynamics-based constraints in MFA will
enforce the exclusion of thermodynamical infeasibilities from ﬂux distribu-
tion solutions. One example of these infeasibilities would be ﬂux distribu-
tions involving ﬂux through the thermodynamically infeasible internal ﬂux
loops mentioned earlier. In addition, these constraints will allow the quan-
tiﬁcation of the ranges in the gradients of metabolite activities required to
drive reactions in the direction of ﬂux reported in all calculated ﬂux
distributions. Knowledge of the permissible ranges of metabolite activities is
essential for the development of kinetic models of metabolism and metabolic
control analysis (33–38).
Estimation of DrG9 of reactions in the iJR904
metabolic model
Formulation of the thermodynamic constraints in TMFA requires knowl-
edge of DrG9 of the reactions in the model, and it must either be estimated or
measured experimentally. Experimental data is available for only a small
fraction of the reactions involved in a genome-scale metabolic model such as
iJR904. Fortunately, the group contribution method provides a means of
estimating DrG9 of nearly every reaction (7,8). In a previous article (21), the
group contribution method was used to estimate DrG9 of 808 of the 931
reactions in the iJR904 model. Recent improvement and expansion of the
group contribution method (M. D. Jankowski, C. S. Henry, L. J. Broadbelt
and V. Hatzimanikatis, unpublished) based on a reﬁtting of the group
contribution values using the thermodynamic data gathered in the NIST
Standard Reference Database (39) and other literature (40–42) have allowed
the estimation of DfG9 for 576 (92%) of the compounds and DrG9 for 891
(96%) of the reactions in the iJR904model. In addition, we have been able to
quantify the ranges of uncertainty in the estimated energy values due to
variances in experimental measurements and the ﬁtting method. All new
estimated thermodynamic data for the iJR904 model are provided in the
Supplementary Material.
In contrast, experimental DrG9measurements taken within 10 K and one
pH unit of the standard conditions of 298 K and a pH of 7 exist for only 52
(5.6%) of the 931 reactions in iJR904. The estimated DrG9, DrG9est, for these
52 reactions agree well with the measured DrG9 (Fig. 1). Literature values
exist for DfG9 of 68 (11%) of the compounds in iJR904, and the DfG9
values from the literature are nearly identical to the estimated DfG9 (Fig. 2).
In all but three cases, the measured DrG9 values fall within the uncertainty
of the estimated DrG9. All of the experimental DrG9 and DfG9 data shown
in Figs. 1 and 2 were part of the dataset to which the group contribution
energies were ﬁt using multiple-linear regression (M. D. Jankowski, C. S.
Henry, L. J. Broadbelt and V. Hatzimanikatis, unpublished).
In our previous article (21), all of the reactions in iJR904 for which the
value DrG9 could not be estimated were lumped to produce a set of net
reactions for which the value DrG9 could be estimated. We then removed
the reactions with unknown DrG9 and replaced them with the net reactions
to produce the iHJ873 model. In the work presented here, although we still
lump together the 40 reactions for which DrG9 cannot be estimated, we do
not remove these 40 reactions from the model stoichiometry. Instead, these
reactions are treated in the manner discussed in the formulation of the
thermodynamic constraints in TMFA described in a following section.
Adjustment of DrG9 for ionic strength
All TMFA studies performed in this article are in terms of metabolite
activities instead of concentrations, making the results of these studies
independent of ionic strength. However, ionic strength will have an effect on
the DrG9 value of the reactions, and the zero ionic strength reference state
upon which the estimated DrG9 values are based differs signiﬁcantly from
the ionic strength of the cytosol in which these reactions take place, between
0.15 and 0.20 M (20). We explore the sensitivity of DrG9 of the reactions in
the genome-scale model to ionic strength using the extended Debye-Hu¨ckel
equation (43,44),
DrG9j ðIÞ ¼ DrG9j ðI ¼ 0Þ  2:303RTA+
m
i
ni;jc
2
i I
1=2
11BI1=2
; (2)
where I is the ionic strength of the solution, ci is the charge of species i, and A
and B are parameters of the extended Debye-Hu¨ckel equation with universally
applicable values of 0.5093 mol1/2/L1/2 and 1.6 mol1/2/L1/2, respectively (45).
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The charge used for each metabolite in the ionic strength studies performed is
the charge of the predominant ionic form of each metabolite at pH 7
determined using pKa estimation software (MarvinBeans pKa estimation
plug-in, Ver. 4.0.3, ChemAxon, Budapest, Hungary). This dramatically
simpliﬁes the calculation, although it might result in less accuracy.
Calculation of DrG9i for reactions involving
transmembrane ion transport
As discussed in a previous article (21), the standard conditions of pH 7
solution and zero ionic strength upon which all DrG9est values are based is
applied to both the extracellular and intracellular environment when
calculating DrG9est for reactions involving the transport of metabolites across
the cellular membrane. As a result, DrG9est for these reactions is based on the
assumption that the electrochemical potential, Dc, and the pH gradient, DpH
FIGURE 1 Comparison of estimated DrG9 to experimentally measured
DrG9. Estimated DrG9 values (solid diamonds) are shown and compared to
experimentally measured DrG9 values (shaded squares) for every reaction
in the iJR904 model for which data exists in the NIST database (39) within
the temperature and pH limitations (288–308 K and pH of 6–8). In some
cases, multiple data points existed in the NIST database at the suitable
conditions. In these cases, the average DrG9 is shown along with the
standard deviation in the data (shaded error bars). The uncertainty in the
estimated DrG9 (solid error bars) calculated from the group contribution
method (22) is also shown verifying that all but three of the measured DrG9
fall within the range of uncertainty of the estimated DrG9.
FIGURE 2 Comparison of estimated DfG9 to DfG9 available in the
literature. EstimatedDfG9 values (solid diamonds) are shown and compared
to literature values of DfG9 (shaded squares) for every compound in the
iJR904 model for which literature data was found (40–42). The uncertainty
in the estimated DfG9 (solid error bars) calculated from the group
contribution method (22) are also shown verifying that all but one of the
literature DfG9 values fall within the range of uncertainty of the estimated
DfG9.
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(pHintracellular – pHextracellular), across the cell membrane is zero. For example,
the ATP synthase reaction in E. coli is typically written in as
4H
1
extracellular1 Pi1ADP/ATP1H2O1 3H
1
cytosolic: (3)
The DrG9est calculated from the group contribution method only applies to
the portion of this reaction that takes place inside the cell, DrG9est; intracellular,
H
1
cytosolic1 Pi1ADP/ATP1H2O: (4)
The energy contribution of the transmembrane transport portion of the
ATP synthase reaction, DrG9transport,
4H
1
extracellular/4H
1
cytosolic; (5)
is the sum of the driving force of DpH across the membrane for the transport
of H1 into the cell, DDpHG, and the energy associated with the transport of
an ion across the membrane, DDcGest,
DrG9est; transport ¼ DDcG1DDpHG: (6)
The overall DrG9est of a reaction energetically coupled to the transport of
an ion across the cell membrane such as ATP synthase is
DrG9est ¼ DrG9est; transport1DrG9est; intracellular: (7)
Under physiological conditions Dc, and DrG9transport depend on DpH.
DDcGest depends upon Dc, which in turn depends on DpH according to the
equations (47)
DDcGðkcal=molÞ ¼ cFDc; (8)
DcðmVÞ ¼ 33:33DpH  143:33
ðbased on a fit of experimental dataÞ; (9)
where c is the net charge transported from outside the cell into the cell, and F
is the Faraday constant in kcal/mV mol. DDpHG depends only on DpH
according to the equation (47)
DDpHGðkcal=molÞ ¼ 2:3 hRT DpH; (10)
where h is the number of protons transported across the membrane. While
DrG9est used in the TMFA constraints for every reaction involving the
transport of ions across the cell membrane will involve a DrG9transport term
according to Eq. 7, the nature of the DrG9transport term depends on the ion
being transported. If protons are transported across the cell membrane as in
ATP synthase, DrG9transport will involve a contribution from both DDpHG and
DDcGest according to Eq. 6. If any other ions are being transported across the
membrane, DrG9transport is equal to DDcGest.
Thermodynamics-based metabolic ﬂux
analysis (TMFA)
To produce ﬂux distributions that are free of thermodynamic infeasibilities
and to allow the exploration of feasible metabolite activities and reaction
driving force, TMFA augments the mass balance constraints of MFA with
additional thermodynamic constraints. Linear thermodynamics-based con-
straints have already been proposed and utilized with MFA to eliminate
thermodynamically infeasible ﬂux loops (14–16), and nonlinear constraints
have been proposed to eliminate ﬂux distributions that utilize reactions that
cannot be thermodynamically feasible under physiological conditions (17).
However, these constraints and methods have never been applied on a
genome scale, and the nonlinear constraints make application to large-scale
systems computationally challenging. In the proposed TMFA, the following
mixed integer linear constraints are used to produce ﬂux distributions free of
any thermodynamic infeasibilities and provide data on feasible metabolite
activity proﬁles and DrG9,
N  v ¼ 0; (11)
0 # vi# zivMax; fi ¼ 1; . . . ; rg; (12)
DrG9i  K1Kzi, 0; fi ¼ 1; . . . ; rjDrG9i is knowng; (13)
DrG9i 1RT +
m
j¼1
ni;j lnðxjÞ ¼ DrG9i; fi ¼ 1; . . . ; r1 L
jDrG9i is knowng; (14)
DrG9i  Kyi, 0; fi ¼ r; . . . ; r1 Lg; (15)
yi1 +
r
j¼1
ai;jzj#+
r
j¼1
ai;j fi ¼ r; . . . ; r1 Lg; (16)
where N is the m 3 r stoichiometric matrix, v is the r 3 1 ﬂux vector, r is
equal to the total number of reactions inN, andm is equal to the total number
of metabolites. The value r is larger than the number of reactions in any
model being used because each of the reversible reactions in the model must
be split into separate irreversible forward and backward component
reactions during the formation of N. This separation is performed so that
the ﬂux through each reaction i can be constrained to be greater than or equal
to zero. A binary use variable, zi, is also associated with each reaction i
speciﬁed in the stoichiometric matrix N. The value of zi is equal to one if the
ﬂux through reaction i, vi, is positive, and zi is equal to zero if vi is zero. This
condition is enforced by the constraint described in Eq. 12. The vMax in Eq.
12 is the upper limit on the ﬂux through any reaction typically set to a
physiologically reasonable value such as 100 mmol/gm DW/h. Equations 11
and 12 represent the mass balance constraints carried over from MFA with
the only difference being the separation of reversible reactions into forward
and backward component reactions.
The new thermodynamic constraints of TMFA begin with Eq. 13, which
ensures that the activity proﬁles and ﬂux distributions generated by TMFA
adhere to the second law of thermodynamics; a reaction ﬂux cannot be
positive unless DrG9i is negative. The K in Eq. 13 is a constant selected to be
large enough that Eq. 13 is always satisﬁed if vi and zi are zero. The terms
involving K in Eq. 13 ensure that the constraint is only applied to reactions
with a non-zero ﬂux. Equation 14 is the Gibbs free energy equation used to
set the value of DrG9i for reaction i given the metabolite activities. In Eq. 14,
ln(xj) is the natural logarithm of the activity of compound j, and ni,j is the
stoichiometric coefﬁcient of compound j in reaction i. In Eq. 14, the energy
contribution for any transport of ions across the cell membrane is accounted
for in the DrG9 term as described in Eq. 7.
As DrG9 of a reaction must be known to formulate the thermodynamic
constraints for a reaction, the constraints described by Eqs. 13 and 14 are not
applied to the reactions in the model with unknown DrG9. Instead, these
reactions are lumped into overall reactions with known DrG9, and special
thermodynamic constraints are applied to the reactions for which DrG9 is
unknown; these constraints are described by Eqs. 14–16. In these equations,
L is the number of lumped reactions, and ai,j is a coefﬁcient equaling one if
reaction j is one of the original reactions with unknown DrG9 that makes up
the lumped reaction i. When Eq. 14 is applied to a lumped reaction, it sets the
value for DrG9i of the lumped reaction. Equation 15 is the thermodynamic
feasibility constraint for the lumped reactions similar to Eq. 13 except that
the binary use variable for each lumped reaction, yi, is set to zero when the
reaction is thermodynamically feasible and one when the reaction is in-
feasible. Equation 16 excludes ﬂux distributions that involve ﬂux through
the set of reactions that comprise an infeasible lumped reaction. The con-
tinuous independent variables of this optimization problem are ln(xj), vi, and
DrG9i, and the binary independent variables are zi, and yi.
In the TMFA of the iJR904model, the 40 reactions with unknown DrG9est
are lumped into 20 reactions with known DrG9est. An additional two internal
ﬂux loops were found within the stoichiometry of the reactions with
unknown DrG9est. Being internal ﬂux loops, the DrG9 of these reactions is
constrained to zero, i.e., Eqs. 15 and 16 constrain the ﬂux through these
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loops to zero. All 20 lumped net reactions and the two internal ﬂux loop
reactions are listed in the Supplementary Material.
TMFA with uncertainty in thermodynamic data
The values of DrG9 used in the thermodynamic constraints of TMFA can be
based on either group contribution estimates or experimental observations,
and they are subject to some uncertainty due to the error allowed when ﬁtting
group contribution energy values or in measuring DrG9 experimentally.
The TMFA must account for this uncertainty to avoid overconstraining
the ranges of possible values for metabolite activities and reaction DrG9 due
to inaccurate DrG9 values. This uncertainty can be accounted for by al-
lowing the DrG9 values used in the TMFA constraints to vary within the
range of the uncertainty.
For example, when the DrG9 values used in TMFA are estimated using
the group contribution method, the potential variance in DrG9est due to uncer-
tainty is captured by allowing the energy contributions of the molecular
substructures used in the group contribution method to vary. The error in the
energy contribution of molecular substructure i, Eg,i, is introduced as a new
variable in the TMFA formulation, and Eg,i is allowed to vary within two
standard errors, s, reported for the group contribution energies in the new
group contribution scheme (M. D. Jankowski, C. S. Henry, L. J. Broadbelt
and V. Hatzimanikatis, unpublished),
2si # Eg;i # 2siði ¼ 1; . . . ; qÞ; (17)
where q is the number of molecular substructures used in the group contri-
bution scheme, and si is the standard error reported for the group contri-
bution value of molecular substructure i. The thermodynamic constraint
speciﬁed in Eq. 14 is now altered to include terms accounting for the
uncertainty in DrG9est,
DrG9est;i1RT +
m
j¼1
ni;j lnðxjÞ1 +
q
j¼1
gi;jEg;j ¼ DrG9i; (18)
where gi,j is the number of occurrences of molecular substructure j being
created or destroyed during reaction i.
RESULTS
Optimization of aerobic growth on glucose
using TMFA
We applied TMFA to determine the maximum growth yield
achievable in the iJR904 genome-scale model. In our TMFA
analysis, we chose to study aerobic growth on glucose as
a carbon source. The concentrations of the extracellular
compounds used as nutrient sources in the model were ﬁxed
to the typical concentrations found in growth media (48).
These concentrations are listed in Table 1. The concentra-
tions of all intracellular species were restricted within the
ranges observed in the cell (between 105 M and 0.02 M)
(49) with the following exceptions. The concentration of H1
in the cell was held constant at 107 M, or a pH of 7. Because
the oxygen concentration selected for the media is 8.2 3
106 M (Table 1) and the oxygen concentration in the cell
cannot exceed the concentration in the media, the bounds on
the oxygen concentration in the cell were set from 107 M to
8.2 3 106 M. The extracellular pH was allowed to vary
between a pH of 4 and 11 to allow for exploration of the
thermodynamically feasible extracellular pH ranges for
E. coli. Speciﬁcs on metabolite uptake and secretion con-
straints used in the analysis are listed in the Appendix.
Initially, uncertainty was not accounted for and si in
Eq. 17 was set to zero. With zero uncertainty, the maximum
growth yield determined from TMFA was zero, suggesting
that growth was not feasible due to the thermodynamic
infeasibility of one or more essential reactions. Under these
conditions, the reaction dihydroorotase,
dihydroorotate1water4n-carbamoyl-L-aspartate1H1 ;
(19)
which must operate in the reverse direction for any biomass
production to occur, is thermodynamically infeasible with a
DrG9est of 4.7 kcal/mol in the reverse direction. Because
E. coli is capable of growing on glucose, this reaction must
be thermodynamically feasible under physiological condi-
tions. One possible way to overcome the infeasibility of this
reaction is to allow for a wider range of values for the acti-
vities of the reactants and the products in this reaction. While
the activities of water and H1 are both lumped into DrG9
and thereby ﬁxed, expanding the minimum and maximum
bounds on the activities of dihydroorotate and n-carbamoyl-
L-aspartate to 0.8 3 105 M and 0.025 M, respectively,
allows sufﬁcient driving force to exist for dihydroorotase to
be thermodynamically feasible. Performing TMFA on the
model with the bounds on the activities of dihydroorotate
and n-carbamoyl-L-aspartate set to these expanded values
results in an optimal growth yield of 0.0923 g biomass/mmol
glucose. This is the same optimal growth yield observed for
the iJR904 model using mass balance constraints alone (50).
Under these conditions, only dihydroorotase is sensitive to
the thermodynamic constraints; there are no other active
thermodynamic bounds.
However, another potential explanation for the infeasibil-
ity of dihydroorotase is inaccuracy in DrG9est, the estimated
values of DrG9. Allowing the error in the group contribution
values to vary within the range of two standard deviations for
the group contribution energies, the optimal growth yield for
the iJR904 model is achievable within the original selected
activity range of 1 3 105 M and 0.02 M. While
experimental evidence does verify that dihydroorotase is a
TABLE 1 Concentrations of nutrients in media
Molecules Concentration
Phosphate 0.056 M
Sulfate 0.0030 M
Ammonium 0.019 M
Sodium 0.16 M
Potassium 0.022 M
Fe21 0.062 M
CO2 0.00010 M
Oxygen 8.2 3 106 M
Glucose 0.020 M
H1extracellular pH 4–11
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thermodynamically unfavorable reaction, the experimentally
observed DrG9 is 1.4 kcal/mol, or 3.3 kcal/mol ,DrG9est.
This deviation is within the range of two standard deviations
for DrG9est of dihydroorotase, which is 4.7 6 4.6 kcal/mol.
These results suggest the importance of accounting for
uncertainty in DrG9est, since ignoring uncertainty can lead to
feasible reactions being incorrectly labeled as infeasible.
Although dihydroorotase can be thermodynamically feasible
in the direction required for growth at the experimentally
observed DrG9 of 1.4 kcal/mol, this reaction is still less
favorable than 91% of the reactions in the iJR904 model.
Interestingly, while dihydroorotase is not part of a multien-
zyme complex in E. coli (51), dihydroorotase is a part of a
multienzyme complex in mammalian cells (52) indicating
that mammalian cells could be utilizing substrate channeling
as a means of overcoming the unfavorable DrG9 of this re-
action without the use of large concentration gradients.
Essential, substitutable, and blocked reactions
Under optimal growth conditions, reactions in E. colimay be
classiﬁed as essential (requiring a non-zero ﬂux for optimal
growth to occur), substitutable (capable of carrying zero or
non-zero ﬂux at optimal growth), or blocked (do not carry
any ﬂux at optimal growth). Flux variability analysis (FVA)
(53) was used to classify the reactions involved in the maxi-
mum production of biomass from glucose in E. coli. In FVA,
the ﬂux of each reaction in the stoichiometric matrix is indi-
vidually minimized and maximized subject to the mass
balance constraints on the metabolites (Eq. 11) and the
growth conditions being analyzed (optimal aerobic growth
on glucose). When the reversible reactions are expressed as
separate forward and backward component reactions, reac-
tions with a positive minimum ﬂux are essential; reactions
with a minimum and maximum ﬂux of zero are blocked; and
reactions with a zero minimum ﬂux and positive maximum
ﬂux are substitutable. When maximizing growth in the
iJR904 model using only mass balance constraints, 272
(29%) reactions are essential, 83 (9%) reactions are substi-
tutable, and 576 (62%) reactions are blocked. When maxi-
mizing growth in the iJR904 model using mass balance and
thermodynamic constraints, 272 (29%) reactions are essen-
tial, 53 (6%) reactions are substitutable, and 606 (65%)
reactions are blocked. The addition of thermodynamic con-
straints causes 30 of the reactions that were classiﬁed as
substitutable using FVA alone to become blocked. These
reactions are all part of thermodynamically infeasible ﬂux
loops in the iJR904 model, demonstrating the effectiveness
of the thermodynamic constraints in restricting the net ﬂux
through these loops to zero while still allowing ﬂux through
the individual reactions involved in the loops. Overall, every
reaction involved in aerobic growth of E. coli on glucose that
is not participating in an internal ﬂux loop is indeed
thermodynamically feasible under the activity conditions
studied. These results hold true whether or not uncertainty in
DrG9est is accounted for as long as the expanded bounds on
the activities of dihydroorotate and n-carbamoyl-L-aspartate
are used.
Sensitivity of TMFA to the ionic strength
reference state
A reference state of zero ionic strength is not an accurate
representation of the intracellular environment in E. coli, as
the ionic strength of the cytosol in E. coli is known to range
between 0.15 and 0.20 M (20). To determine the effect of the
high intracellular ionic strength on DrG9est, we utilized Eq. 2
to adjust the reference ionic strength of DrG9est for all of the
reactions in the iJR904 model to a new reference state of
0.2 M. The effect of ionic strength on DrG9est was found to
be very small for most reactions. For 95% of the reactions in
iJR904, the difference between DrG9est (I¼ 0) and DrG9est (I¼
0.2 M) is ,1 kcal/mol (Fig. 3). There are six exceptional
reactions in the iJR904model for which DrG9est (I¼ 0.2 M) is
.10 kcal/mol,DrG9est (I ¼ 0). However, these six reactions
also have DrG9est (I ¼ 0) values that are all ,80 kcal/mol,
and these reactions are all large lumped reactions involved in
membrane lipid metabolism.
In the case of thermodynamic bottleneck reactions such as
dihydroorotase, even the small change to DrG9est that results
from the adjustment for ionic strength is sufﬁcient to make a
reaction become infeasible. For dihydroorotase, DrG9est (I ¼
0.2 M) is 0.73 kcal/mol higher than DrG9est (I¼ 0). While this
is sufﬁcient to make this reaction infeasible under the
concentration ranges studied when the uncertainty is set to
zero, this is not sufﬁcient to make this reaction infeasible
FIGURE 3 Effect of ionic strength on DrG9. A histogram of the differ-
ences between DrG9 at an ionic strength of zero (DrG9 (I¼ 0)) and DrG9 at
an ionic strength of 0.2 M (DrG9 (I ¼ 0.2 M)) for all of the reactions in the
iJR904 model. The bin sizes in the histogram are all 0.25 kcal/mol. Greater
than 95% of the differences are within 1 kcal/mol of zero.
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when the uncertainty is accounted for. Overall, the variation
in DrG9est due to the ionic strength of solution falls well
within the uncertainty in DrG9est.
Thermodynamic variability analysis (TVA): ranges
of the Gibbs free energy
The permissible ranges of the new system variables of
metabolite activity and DrG9 introduced in TMFA can be
explored using linear optimization in a methodology we call
thermodynamic variability analysis (TVA), which is analo-
gous to FVA. In TVA, the activity of each metabolite and
DrG9 of each reaction are minimized and maximized subject
to the thermodynamic and mass balance constraints. TVA
allows for the identiﬁcation of the thermodynamic bottle-
necks in the metabolic network. Thermodynamic bottlenecks
are reactions for which DrG9 is constrained to be approxi-
mately zero, meaning these reactions must operate very close
to equilibrium. Any small decrease in the concentrations of
the reactants or increase in the concentrations of the products
in these reactions is sufﬁcient to force the ﬂux to zero
(18,19).
We ﬁrst studied the system in the absence of uncertainty,
i.e., TVA was performed with the uncertainty set to zero
while using the expanded bounds on the dihydroorotase
reactants and the default bounds on the remaining metabolite
activities (black error bars in Fig. 4). Under these
conditions, the DrG9 values of the reactions are constrained
by the ranges of the values of the metabolite activities that
allow every reaction required for optimal growth to be
simultaneously thermodynamically feasible (Fig. 5 and
Table 2). Only one reaction, dihydroorotase, has a DrG9
that is constrained to near zero, indicating that this reaction is
the only thermodynamic bottleneck under these conditions.
We next performed TVA with the uncertainty in DrG9
accounted for by allowing the error in the group contribution
energies to vary according to Eq. 17. The expanded bounds
on activities of the metabolites in the dihydroorotase reaction
were also used to keep the conditions consistent with the
TVA study conducted with uncertainty set to zero and allow
for comparison of the results. Due to the relatively large
uncertainty ranges in DrG9, all of the reactions can achieve a
wide range of DrG9 values, and none of the DrG9 values are
constrained near zero, indicating that no reactions behave as
thermodynamic bottlenecks under these conditions (red
error bars in Fig. 4).
Thermodynamic variability analysis (TVA): ranges
of metabolite activity
TVA was also used to study the ranges of the activities of the
metabolites. When TVA was performed with the uncertainty
in DrG9est set to zero, the activities of the metabolites involved
in the bottleneck reaction dihydroorotase were highly
constrained (black error bars in Fig. 5). The activity of the
primary product of the reaction, dihydroorotate, is ﬁxed at
the minimum concentration while the primary reactant,
n-carbamoyl-L-aspartate, is ﬁxed at the maximum concen-
tration. When the uncertainty in DrG9est is accounted for,
concentrations of most compounds are nearly unconstrained
(red error bars in Fig. 5). One important exception is
oxygen. As mentioned earlier, the intracellular oxygen
concentration is always ﬁxed to the very low concentration
range of ,105 M because the intracellular oxygen con-
centration must be lower than the extracellular concentration
for diffusion into the cell to occur. Interestingly, this limita-
FIGURE 4 Ranges for DrG9 of required and substitutable reactions. The
thermodynamically feasible ranges for DrG9 of the 45 essential and sub-
stitutable reactions with the narrowest feasible DrG9 range. The ranges are
the widest when the uncertainty in DrG9 is accounted for by allowing the
group contribution energy values to vary within their standard errors (red
error bars). If the uncertainty is assumed to be zero, the feasible ranges for
DrG9 decrease signiﬁcantly (black error bars), and DrG9 of the reaction
dihydroorotase becomes constrained to near zero. When the two error bars
do not overlap completely, the larger error bar always corresponds to the
range calculated, accounting for uncertainty.
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tion does not have a large effect on the cell as only two
essential reactions require oxygen as a reactant, cytochrome
oxidase bo3 and 2,3-diketo-5-methylthio-1-phosphopentane
degradation, and these reactions have very negative DrG9est
values of 36.8 and 124 kcal/mol, respectively, ensuring
thermodynamic favorability despite small reactant concen-
tration.
Experimentally measured metabolite concentrations are
available from a variety of literature sources (49,54,55) for
24 (3.8%) of the metabolites in iJR904. These concentrations
are compared with the thermodynamically feasible activity
FIGURE 5 Thermodynamically feasible activity ranges. The thermody-
namically feasible metabolite activity ranges are shown for all of the
compounds with a feasible range that is less than the bounds placed on the
metabolite activities (0.01–20 mM with the exception of the compounds
listed in Table 1, n-carbamoyl-L-aspartate and dihydroorotate). When the
uncertainty in the estimated DrG9 values is assumed to be zero, the
metabolite activities are the most tightly constrained (black error bars).
Tightly constrained metabolites include the main reactant and product of the
bottleneck reaction dihydroorotase, n-carbamoyl-L-aspartate (cbasp) and
dihydroorotate (dhor), respectively. When the uncertainty in the estimated
DrG9 values is accounted for, the feasible activity ranges increase signif-
icantly (red error bars). When the two error bars do not overlap completely,
the larger error bar always corresponds to the range calculated, accounting
for uncertainty.
TABLE 2 Most thermodynamically constrained reactions
Abbreviation Reaction name
DHORTS(r) Dihydroorotase (reverse)
TRPAS2(r) Tryptophanase (reverse)
O2t O2 transport via diffusion
MTHFD Methylenetetrahydrofolate dehydrogenase
TRDR Thioredoxin reductase
CO2t(r) CO2 transport via diffusion (reverse)
ACONT Aconitase
MTHFC Methenyltetrahydrofolate cyclohydrolase
PPM(r) Phosphopentomutase (reverse)
PGMT(r) Phosphoglucomutase (reverse)
PGAMT(r) Phosphoglucosamine mutase (reverse)
PGM(r) Phosphoglycerate mutase (reverse)
PRAMPC Phosphoribosyl-AMP cyclohydrolase
A5PISO Arabinose-5-phosphate isomerase
TPI Triose-phosphate isomerase
IPPMIb(r) 2-isopropylmalate hydratase (reverse)
IPMD 3-isopropylmalate dehydrogenase
IPPMIa(r) 3-isopropylmalate dehydratase (reverse)
MDH Malate dehydrogenase
PGCD Phosphoglycerate dehydrogenase
NH3t Ammonia reversible transport
MTRI 5-methylthioribose-1-phosphate isomerase
PRMICIi Phosphoribosyl imidazolecarboxamide isomerase
ALARi Alanine racemase
GLUR(r) Glutamate racemase (reverse)
AGMHE ADP-glycero-manno-heptose epimerase
RPE Ribulose 5-phosphate 3-epimerase
AIRC3(r) Phosphoribosylaminoimidazole carboxylase
(reverse)
DAPE Diaminopimelate epimerase
RPI(r) Ribose-5-phosphate isomerase (reverse)
GAPD Glyceraldehyde-3-phosphate dehydrogenase
FUM Fumarase
PEPT_EC Ethanolamine phosphotransferase
THRAr(r) Threonine aldolase (reverse)
PGI Glucose-6-phosphate isomerase
DHDPRy Dihydrodipicolinate reductase
PGK(r) Phosphoglycerate kinase (reverse)
PRAIS Phosphoribosylaminoimidazole synthase
MTHFR2 5,10-methylenetetrahydrofolate reductase
PRAIi Phosphoribosylanthranilate isomerase
AICART Phosphoribosylaminoimidazolecarboxamide
formyltransferase
S7PI Sedoheptulose 7-phosphate isomerase
HCO3E HCO3 equilibration reaction
FBA Fructose-bisphosphate aldolase
ENO Enolase
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ranges determined from TMFA (Fig. 6), and for all but one
metabolite (pyruvate) the experimentally measured concen-
tration data falls within the thermodynamically feasible
activity range when uncertainty in DrG9est is set to zero.
Pyruvate falls within the thermodynamically feasible activity
range when DrG9est is allowed to vary within the uncertainty.
Surprisingly, the measured metabolite concentrations fall
near the logarithmic mean (
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
XMaxXMin
p
) of the minimum and
maximum feasible activities determined from TMFA with
zero uncertainty for a signiﬁcant number of important metab-
olites. In particular, 6pg, f6p, NADH, NAD1, akg, g3p, g6p,
GTP, asp, and ADP all fall on or near the logarithmic mean
of the minimum and maximum feasible activities. This is of
particular signiﬁcance because the concentrations of the
metabolites NADH, NAD, and ADP are all under strict
regulatory control. One purpose for maintaining the concen-
trations of these metabolites near the center of the thermo-
dynamically feasible range could be to maximize ﬂexibility.
The activity of these metabolites can deviate signiﬁcantly
from the intrinsic value before any of the reactions in which
the metabolites are involved become infeasible.
Predicting candidate reactions for regulation
based on thermodynamics
As it has been recently proposed (2), the magnitude of DrG9
of a reaction has some implications for the possibility that
this reaction is subject to regulation. It has been proposed
that reactions with a DrG9 that is close to zero (the reactions
we refer to as thermodynamic bottlenecks) have only limited
potential for regulation as these reactions are very sensitive
to minor perturbations in the concentrations of their reac-
tants. In contrast, reactions with a highly-negative DrG9 have
the thermodynamic potential to serve as regulatory control
points for the pathways in which they participate because
enzyme regulation will be the dominant mechanism for
control of the ﬂux through these reactions. The DrG9 range
data generated by TVA can be used with this proposed
criterion to determine all of the reactions in the genome-scale
iJR904 model that have the potential to be regulatory control
points. Speciﬁcally, we identiﬁed the reactions in the iJR904
model for which the maximum possible DrG9 as calculated
with TVA is ,1.0 kcal/mol, meaning none of these
reactions can reach equilibrium under the concentration
ranges studied (Table 3). In our analysis of candidate
reactions for regulation, we utilized the DrG9 range data
produced assuming the uncertainty in DrG9est is zero, because
we want to focus the analysis on the range of DrG9 values
possible given variations in metabolite concentrations alone.
While the analysis presented previously (2) focuses solely on
the central carbon pathways, we ﬁnd candidates for regula-
tion in a variety of pathways in the cell. Because the
metabolite concentration ranges that we explore are much
larger than those used previously (2), we do not identify as
many candidate reactions for regulation in central carbon
(we ﬁnd six of the 14 reactions reported in Kummel et al.
(2), only three of which carry ﬂux; the rest do not carry ﬂux
in our analysis because the operating conditions used to
generate our ﬂux distributions are different from those used
in (2)) .
Typically, a key step for regulation in a metabolic pathway
in the cell is the ﬁrst step of a linear pathway (56). Therefore,
we studied the locations of the candidate reactions for re-
gulation identiﬁed based on thermodynamics, and 30 of the
86 reactions serve as the ﬁrst step in the pathways in which
they participate while ﬁve reactions serve as the ﬁnal step.
For example, in aromatic amino-acid biosynthesis, DDPA is
the ﬁrst step in the pathway that produces chorismate; CHORM
is the ﬁrst step in the pathways that produce phenylalanine
and tyrosine; PPNDH is the ﬁrst step of the pathway that
produces only phenylalanine; and ANS is the ﬁrst step of the
pathway that produces tryptophan. All of these reactions
belong to branching nodes in the aromatic amino-acid
FIGURE 6 Comparison to metabolic concentrations reported in the
literature. Experimentally measured concentration ranges (green diamonds
and green error bars) reported in the literature (49,54,55) are shown along
with the thermodynamically feasible activity ranges for the same metabolites
found using TMFA with no uncertainty (black circles and error bars). The
black circles show the logarithmic mean for the feasible activity range
(
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
XMaxXMin
p
). The feasible activity ranges for the metabolites found using
TMFA accounting for uncertainty in estimated DrG9 values are also shown
(red error bars). When the two error bars do not overlap completely, the
larger error bar always corresponds to the range calculated, accounting for
uncertainty.
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biosynthesis pathways (56), and all four of these reactions
were identiﬁed as candidates for regulation using TVA.
The analysis presented here has three advantages over the
analysis performed in Kummel et al. (2). First, the thermo-
dynamic data used in our analysis is far more complete,
covering 891 of the reactions in the iJR904 model as
opposed to 132 in Kummel et al. (2). This allows for the
identiﬁcation of candidates for regulation in every known
metabolic pathway in addition to central carbon. Second,
TMFA combines the quantiﬁcation of the ﬂuxes in the cell
metabolism with the assessment of thermodynamic feasibil-
ity in a single step. Thus no ﬂux distributions are produced
that must later be corrected due to thermodynamic infeasi-
bilities found. Finally, the metabolite concentration ranges
used in our analysis are far less constrained, allowing a more
complete exploration of the potential ranges for DrG9 of the
reactions in the model.
Exploring the limits on physiologically important
concentration ratios
Thermodynamically unfavorable reactions required to take
place in cell metabolism are typically driven by hydrolysis of
the triphosphate bond in ATP to generate ADP. As such, the
TABLE 3 Candidate reactions for regulation
Reaction Pathway Reaction Pathway
GLYCTO2 Alternate carbon metabolism C160SN* Membrane lipid metabolism
GLYCTO3 Alternate carbon metabolism C181SN* Membrane lipid metabolism
GLYCTO4 Alternate carbon metabolism C141SN* Membrane lipid metabolism
PPA Anaplerotic reactions C161SN* Membrane lipid metabolism
MDRPD Arginine and proline metabolism PSD_EC Membrane lipid metabolism
DKMPPD Arginine and proline metabolism CYSTL* Methionine metabolism
G5SADs Arginine and proline metabolism RNDR1 Nucleotide salvage pathways
ORNDC* Arginine and proline metabolism RNDR2 Nucleotide salvage pathways
ADMDCr* Arginine and proline metabolism RNDR4 Nucleotide salvage pathways
PPTGSy Cell envelope biosynthesis RNDR3 Nucleotide salvage pathways
UDCPDP Cell envelope biosynthesis RNTR1 Nucleotide salvage pathways
KDOPP Cell envelope biosynthesis RNTR2 Nucleotide salvage pathways
KDOPS* Cell envelope biosynthesis RNTR3 Nucleotide salvage pathways
UAPGR Cell envelope biosynthesis RNTR4 Nucleotide salvage pathways
USHD Cell envelope biosynthesis TMDS* Nucleotide salvage pathways
PPCDC Cofactor and prosthetic biosynthesis CYTBO3 Oxidative phosphorylation
GTPCI* Cofactor and prosthetic biosynthesis FDH2 Oxidative phosphorylation
QULNS Cofactor and prosthetic biosynthesis FDH3 Oxidative phosphorylation
ASPO3* Cofactor and prosthetic biosynthesis HYD1 Oxidative phosphorylation
ASPO4* Cofactor and prosthetic biosynthesis HYD2 Oxidative phosphorylation
ASPO5* Cofactor and prosthetic biosynthesis PGLz Pentose phosphate cycle
NNDPR Cofactor and prosthetic biosynthesis GLUPRT* Purine and pyrimidine biosynthesis
DNTPPA* Cofactor and prosthetic biosynthesis IMPC(r) Purine and pyrimidine biosynthesis
ADCL Cofactor and prosthetic biosynthesis PRFGS Purine and pyrimidine biosynthesis
ASP1DC* Cofactor and prosthetic biosynthesis DHORD2 Purine and pyrimidine biosynthesis
GTPCII2* Cofactor and prosthetic biosynthesis DHORD5 Purine and pyrimidine biosynthesis
DB4PS* Cofactor and prosthetic biosynthesis OMPDCy Purine and pyrimidine biosynthesis
DHPPDA2* Cofactor and prosthetic biosynthesis DHDPS* Threonine and lysine metabolism
RBFSa Cofactor and prosthetic biosynthesis DAPDCy Threonine and lysine metabolism
RBFSb Cofactor and prosthetic biosynthesis GLCpts* Extracellular transport
SULR(r)z Cysteine metabolism DHQS Aromatic amino acid metabolism
CYSSy Cysteine metabolism CHORS Aromatic amino acid metabolism
SULabc* Cysteine metabolism (transport) DHQD Aromatic amino acid metabolism
GCALDDy Folate metabolism DDPA* Aromatic amino acid metabolism
FTHFD Folate metabolism PPNDH* Aromatic amino acid metabolism
PDHz Glycolysis/gluconeogenesis CHORM* Aromatic amino acid metabolism
GLCS1 Glycolysis/gluconeogenesis IGPS Aromatic amino acid metabolism
IGPDH* Histidine metabolism ANS* Aromatic amino acid metabolism
HISTDy Histidine metabolism THRD_L* Val, Leu, and isoleu metabolism
IG3PS Histidine metabolism ACLS* Val, Leu, and isoleu metabolism
PRATPP Histidine metabolism DHAD2 Val, Leu, and isoleu metabolism
C140SN* Membrane lipid metabolism DHAD1 Val, Leu, and isoleu metabolism
C120SN* Membrane lipid metabolism OMCDC Val, Leu, and isoleu metabolism
*Reaction is the ﬁrst step in the pathway leading to the pathway end-product.
yReaction is the ﬁnal step in the pathway producing pathway end-products.
zReaction also identiﬁed in the literature (2) as a candidate for regulation.
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ratio of the ATP activity to the ADP activity is an important
and carefully regulated quantity in the cell (54), and DrG9 of
many reactions in the cell metabolism depend on this ratio.
Similarly, oxidation and reduction reactions taking place
in cell metabolism typically utilize NAD(P)1 as electron
sinks and NAD(P)H as electron sources. The DrG9 of these
oxidation and reduction reactions depend on the ratio of
NAD1 to NADH and NADP1 to NADPH, and these ratios
have also been found to be under strict regulatory control
(54).
We utilized TVA to determine if the physiological levels
of the concentration ratios ATP/ADP, NAD/NADH, and
NADP/NADPH maintained inside the cell are due to ther-
modynamic constraints by exploring the range of thermo-
dynamically feasible values for these ratios. We also used
TVA to study the limits on the ratio of the intracellular pH to
the extracellular pH as all transport of ions across the cell
membrane depends on this ratio. The minimum and max-
imum ratios found are shown in Table 4 along with the
values for these ratios found in the literature (47,49,54). We
found that without accounting for uncertainty in the group
contribution method, all of the ratios found in the literature
nearly ﬁt within the thermodynamically feasible ranges for
the ratios. Interestingly, the physiologically observed ratio
for NAD/NADH is very close to the minimum ratio
predicted by TVA, whereas the physiologically observed
ratio of NADP/NADPH is very close to the maximum ratio
predicted by TVA. This suggests that the values of these
physiologically important quantities at optimal growth con-
ditions are determined by the constraints imposed by the
thermodynamic properties of the entire metabolic network.
When accounting for uncertainty, the estimated ratios
NADP/NADPH and NAD/NADH span the entire range of
values possible given the concentration limits of 105 M
and 0.02 M, whereas the ratios ATP/ADP and H1int/H
1
ext
remain close to the ranges estimated by the analysis without
uncertainty.
The minimum value for the ATP/ADP ratio is constrained
by thermodynamics because DrG9 of every kinase reaction
in the cell depends on this ratio. As the ATP/ADP ratio
decreases, DrG9 of every reaction driven by the dephospho-
rylation of ATP increases. This includes the many essential
phosphorylase and kinase reactions in the nucleotide salvage
pathway responsible for the production of all the other
triphosphate nucleotides in the cell. All of these reactions
transfer one phosphate from ATP to another nucleotide such
as GDP, UDP, or CDP to create ADP and either GTP, UTP,
or CTP, respectively. Because the energies of the triphos-
phate bonds being created and destroyed in these reactions
are essentially identical, DrG9 of these reactions are all
approximately zero. Therefore, these reactions must be
driven entirely by the concentration gradient between the
reactants and products. Driving the ATP/ADP ratio to very
low levels also drives the ratios GTP/GDP, UTP/UDP, CTP/
CDP, and nearly every other triphosphate/diphosphate pair
in the cell, to even lower levels to maintain a favorable
concentration gradient. A low ATP/ADP ratio results in an
unfavorable concentration gradient for every kinase reaction
in the cell, reducing the energy generated by the kinase
reactions.
The maximum H1intracellular/H
1
extracellular ratio is constrained
by thermodynamics because DrG9 of every reaction involv-
ing the transport of ions across the cell membrane depends
on this ratio. Many transport reactions in E. coli, most
notably ATP synthase, are powered by the transport of H1
across the cell membrane. As the extracellular H1 concen-
tration decreases, the transmembrane proton concentration
gradient becomes more unfavorable reducing the power
generated by the transport of the proton into the cell until
insufﬁcient power is provided to drive these reactions in the
direction required for growth.
DISCUSSION
The addition of thermodynamic constraints to MFA results
in both improved accuracy and expanded applicability
of ﬂux balance analysis methods. The ﬂux distributions
generated using TMFA do not involve ﬂux through any
thermodynamically unfavorable ﬂux loops, and no thermo-
dynamically unfavorable reactions given the concentration
ranges found in the cell are utilized. Furthermore, TVA
allows the exploration of the thermodynamically feasible
values for DrG9 of the reactions and the metabolite activities.
Some differences do exist between the results presented here
and the results presented in the previously published article
on this topic (21). These differences are a result of the
TABLE 4 Thermodynamically feasible physiologically important concentration ratios
Ratio reported in literature Min ratio with no uncertainty Max ratio with no uncertainty Minimum ratio Maximum ratio
ATP/ADP 3.2* 0.17 2.0 3 103§ 0.022 2.0 3 103§
NAD/NADH 19y 15 2.0 3 103§ 0.00050{ 2.0 3 103§
NADP/NADPH 1.2y 0.0086 1.1 0.00050{ 2.0 3 103§
H1int/H
1
ext 0.025–6.3
z 0.0010{ 5.0 0.0010{ 7.1
*From Albe et al. (49).
yFrom Andersen and Meyenburg (54).
zFrom Neidhardt and Curtiss (47).
{Equal to the minimum ratio possible given the bounds on the concentrations of these species.
§Equal to the maximum ratio possible given the bounds on the concentrations of these species.
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combination of improvements in the thermodynamic esti-
mates and an improved ability of TMFA to assess the
feasibility of reactions by accounting for all possible
metabolite concentrations rather than just mM concentra-
tions used in the previous article.
Uncertainty remains an issue when utilizing the group
contribution method to analyze the effect of thermodynamic
constraints on metabolite activities and reaction DrG9. All of
the feasible ranges for the metabolite activity ratios studied in
this article with no uncertainty allowable in DrG9 encom-
passed the values observed in literature. When uncertainty
in DrG9est is accounted for, nearly all of the metabolite acti-
vities are completely unconstrained, and all of the experi-
mentally measured metabolite activities fall within the range
of possible values obtained from TVA. The feasible ranges
for DrG9 and metabolite activities determined from TVA
accounting for uncertainty in DrG9 are far larger than the
true feasible ranges for these quantities. The ranges deter-
mined from TVA with no uncertainty allowable are much
closer to the true feasible ranges.
Regardless of uncertainty in DrG9est, very few of the
metabolites in E. coli are affected by the thermodynamic
constraints at all. The majority of the reactions in E. coli are
thermodynamically favorable, allowing the reactions to
remain active under a wide variety of metabolite concentra-
tions and granting the cell a large degree of versatility. While
this thermodynamic ﬂexibility prevents the determination of
exact values for DrG9 of the reactions, the estimated
magnitudes of DrG9 are determined, which can provide
valuable insight for the potential of a reaction to undergo
regulation. To tightly constrain metabolite activities and
reaction DrG9 based on thermodynamic constraints, either
a thermodynamic optimization objective must be utilized
as done in the work by Beard and Qian (17), or additional
nonlinear constraints involving kinetics must be added to the
TMFA formalism.
The activity ratio study performed does demonstrate that
while the values for the activities of single metabolites have a
wide range of feasible values, constraints do exist on the
activity ratios of some metabolites of physiological signif-
icance. Important metabolite pairs that appear together in
many different reactions such as ATP and ADP, NAD and
NADH, NADP and NADPH, and intracellular and extracel-
lular protons become thermodynamically coupled to the
activity ratios of many other metabolites in the cell. This
coupling results in a thermodynamic constraint on these
ratios. Interestingly, while the physiological concentrations
of key metabolites in the cell are maintained near the middle
of the feasible activity range, the NAD/NADH ratio is main-
tained near the minimum feasible value while the NADP/
NADPH ratio is maintained near the maximum feasible
value.
While ionic strength can have a large effect on metabolite
activities causing the activity of a metabolite to differ from
the concentration of the metabolite by over 20%, ionic
strength has a much smaller impact on DrG9 of the reactions.
Therefore, the thermodynamic feasibility of reactions can
often be accurately assessed from DrG9 of the reactions
based on a reference ionic strength of zero. The difference
between DrG9 (I¼ 0) and DrG9 (I¼ 0.2 M) is also typically
much smaller than the uncertainty involved in DrG9 (I ¼ 0)
making uncertainty the more important factor to take into
account. However, these adjustments are based on the
extended Debye-Hu¨ckel equation, which is applicable for
solutions with an ionic strength of ,0.1 M. Applying this
relationship to adjust DrG9 to an ionic strength of 0.2 Mmay
affect some of the reported results. The extent of these
differences is the subject of ongoing investigations.
Finally, it is important to note that neither the key
thermodynamic bottleneck dihydroorotase nor most of the
candidates for regulation identiﬁed were a part of the central
carbon chemistry of the cell. This emphasizes the importance
of applying thermodynamic analysis to large-scale genome-
based models to account for the highly coupled nature of
thermodynamic constraints.
APPENDIX: MFA CONDITIONS
MFA studies were performed under a speciﬁc set of constraints on the
metabolites the cell could uptake from or excrete to the cell surroundings.
The ability of E. coli to grow optimally under aerobic conditions was studied
using glucose as a primary carbon source. The uptake of glucose and oxygen
from the environment into the cell was restricted to 0.01 and 0.02 Mol/g dw
h, respectively (29). The uptake and excretion of sulfate, phosphate, and
ammonium, CO2, water, and hydrogen ion were left unrestricted and the
ATP maintenance requirement was ﬁxed at 7.6 mmol/g dw h (24,30,57).
Under these conditions, the optimal growth on glucose was found to be
0.923 g biomass/g dw h, with a yield of 0.0923 gram biomass per mmol
of glucose uptake (0.512 g biomass/g glucose). This optimal growth
yield agrees well with the optimal growth yields for E. coli under similar
conditions reported in the literature from MFA and experiments (30).
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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